The Role of TROP2 as a Biomarker in NSCLC

Opinion
Video

Edward B. Garon, MD, MS, and Anne S. Tsao, MD, provide an overview of TROP2 as a target for patients with non–small cell lung cancer.

Related Videos
Related Content